secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001193125-23-264152
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences amends bylaws to adopt universal proxy rules and enhance stockholder proposal disclosure
--------------------------------------------------------------------------------

- Board approved amended bylaws effective Oct 26, 2023.
- Amendments require compliance with SEC Rule 14a-19 for proxy solicitations supporting non-Board nominees.
- Enhanced procedural and disclosure requirements for stockholder director nominations and other business proposals.
- Includes technical, modernizing and clarifying changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312523264152/0001193125-23-264152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312523264152/d537796d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-264152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer